News

Dr. Anna Veiga is leading the project CRISPR/Cas9 human embryo genome editing (GE) for the study of genes related to early embryo development.

To equilibrate the gene expression between XX females and XY males, one of female X chromosomes is inactivated. Researchers from IDIBELL Regenerative Program has discovered that this inactivation is affected in bone marrow aged stem cells.

The research group led by Dr. Alessandra Giorgetti, leader of the research group “Biology of Hematopoietic Stem Cells and Leukemogenesis” of IDIBELL, and professor at the UB, has received a grant of € 15,000 from the GESMD (Spanish Group of Myelodysplastic Syndromes), a group of which Giorgetti is an active member.

With this project, Dr. M Carolina Florian, aims to improve the survival and quality of life of elderly patients undergoing chemotherapy. The project will study the regeneration of bone marrow tissues after cancer therapy and will seek new strategies to enhance it.

We are organizing a scientific session with all the awarded projects, where all participant groups will present the research performed and the collaborations born thanks to these projects.

Jordi Guiu joins to P-CMR[C] as group leader and opens the Cell Plasticity and Regeneration group

Dr. M. Carolina Florian (Program of Regenerative Medicine, IDIBELL, Spain) and Prof. Medhanie Mulaw (Ulm University, Germany) will receive more than 800.000 euros from the “La Caixa” Foundation to apply deep learning to investigate leukemia in the elderly

Regenerative medicine scientists at IDIBELL in collaboration with partners at Ulm University (Germany) have demonstrated that inhibition of Cdc42 with CASIN can pharmacologically extend lifespan.